Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
The new Biolys provides higher concentration of L-lysine
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
He is a Chartered Accountant with more than 19 years of extensive experience
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Subscribe To Our Newsletter & Stay Updated
